Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”), a medical diagnostics company focused on developing rapid near-patient testing solutions for critical care, today announced that it has entered ...

AI is revolutionizing the IVD market by enhancing diagnostic accuracy and speed. Key opportunities lie in AI integration across workflows, cloud solutions, regulatory support, and supply chain ...

New Delhi: The government has for the first time introduced India-specific performance standards for diagnostic laboratories in order to improve the accuracy, consistency, and reliability of test ...

The cases of H3N2 flu have been reported in Delhi and other NCR cities. A recent survey said that nearly 69% of households in Delhi-NCR have reported at least one member down with flu-like illness ...

A new £11.7m diagnostic centre that will "take the pressure off" a county's hospitals has been officially opened. The Corby Community Diagnostic Centre (CDC) at the Willowbrook Health Centre site will ...

aDivision of HIV, Infectious Diseases and Global Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA bDivision of Pulmonary and Critical Care ...

NEW YORK – Spanish diagnostic firm MiMark Diagnostics is progressing toward clinical validation and commercialization of its minimally invasive test for endometrial cancer. The spinout of Vall ...

Researchers at the Johns Hopkins University School of Medicine and the National Institutes of Health, in collaboration with the UK Biobank and the University of Turin, Italy, have identified a ...

Quest Diagnostics Inc. said Monday the first blood-based biomarker test to assess the risk of developing Alzheimer’s disease is now available for consumer purchase. The test helps assess the risk of ...

Watch as the 4000-degree proto-lightsaber is unleashed on a variety of objects in a jaw-dropping destruction test. From steel to stone, nothing stands a chance. This is more than a test—it's a glimpse ...

The FDA approved the Oncomine Dx Target Test for identifying HER2-mutant NSCLC patients eligible for Hernexeos, an oral tyrosine kinase inhibitor. Hernexeos offers a new treatment option for ...

What just happened? Thermal Grizzly has released a new open-air test bench aimed at competitive overclockers and hardware engineers. The product, called the "der8enchtable," was developed in ...